STEPHEN BELL: Open Payments
NPI 1538426184 · PORT NECHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 44 payments from 14 companies in 2025. Trend: 2023 $253 · 2024 $497 · 2025 $794
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $121 |
| Novo Nordisk Inc | 5 | $100 |
| PFIZER INC. | 5 | $86 |
| Dexcom, Inc. | 4 | $84 |
| Antares Pharma, Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $52 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Corcept Therapeutics | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $18 |
Products named: Kerendia, Wegovy, Dexcom G6 Transmitter, XYOSTED, NURTEC ODT, QULIPTA, MOUNJARO, UBRELVY.
Industry payments across TX — which companies pay providers there.
